Being born with two X chromosomes brings a host of health benefits, and recognising this could lead to personalised medical ...

Insilico announced the launch of its innovative cardiometabolic disease portfolio at BIO Europe 2025. The portfolio covers a ...

Insilico announced the launch of its innovative cardiometabolic disease portfolio of unique highly-differentiated molecules ...

The field of biotechnology has always transformed cutting-edge science into life-changing medicines, but today that transformation is happening at a staggering pace.

As the immune system ages, it reacts more slowly to pathogens, vaccines become less effective, and the risk of cancer ...

A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of ...

A Japanese-led research team has developed AUN, a groundbreaking immune-independent bacterial cancer therapy that uses two ...